Magellan Guewo-Fokeng

Prof
Diabetes
University of Yaounde
Cameroon

Biography

These findings provide a variety drug development targets according to the genetic risk in the form of signal pathways that can reduce the progression of multiple metabolic phenotypes or the risk of their complications by personalization of medicine. These findings provide a variety drug development targets according to the genetic risk in the form of signal pathways that can reduce the progression of multiple metabolic phenotypes or the risk of their complications by personalization of medicine.

Research Intrest

Diabetes,Medicine,Healthcare,Public Health

List of Publications
Putative trans-regulator network of the krüppel-like factor 14 (KLF14): Potentials sources of information to personalized medicine in type 2 diabetes mellitus and related traits